Deep Learning and Electrophysiology Tools Advance Organoid Drug Screening
New technologies enhance organoid screening for drug development, including a physics-informed deep learning framework for quantification and an automated electrophysiology system for functional analysis.
Two recent developments aim to accelerate the use of patient-derived organoids in drug discovery: a physics-informed deep learning framework for quantifying organoid responses and an automated system for measuring live electrophysiological activity within 3D neural cultures.
A study published in npj Digital Medicine presents DICE-2DSeg, a graph-enhanced framework that combines OCT-inspired intra-slice coherent enhancement with graph-based inter-slice context aggregation. Validated on 93 volumes across diverse cancer types and drugs, the high-throughput variant achieves a 14-fold speedup over nnUNet3D while retaining 93.65% of its accuracy. It establishes a new state-of-the-art for drug-responsive remnants between 0 and 100 micrometers and maintains high fidelity for clusters larger than 100 micrometers.
Diagnostic Biochips has developed SomaFocus, an automated system that inserts ultra-fine silicon probes into intact organoids to measure live electrophysiological activity. The technology generates data on coordinated neuronal firing and network dynamics, which are often invisible to purely structural or molecular assays. SomaFocus is primarily focused on brain organoids, spheroids, and assembloids, but also works with intestinal, retinal, and skin organoids.
Organoids are genetically programmable models that preserve key characteristics of patient tissues, offering opportunities for disease modeling, target validation, biomarker discovery, and therapeutic evaluation. However, challenges remain, including variability between organoids, maturation state, and the need for better functional readouts.
The DICE-2DSeg work was supported by several Chinese research programs and utilized organoid samples and computing resources from Regenovo Ltd. The SomaFocus system is designed to meet the automation needs of drug discovery pipelines.